Joe Rogan Stunned As Mel Gibson Reveals How Three Of His Friends All Cured Stage 4 Cancers

In a recent episode of The Joe Rogan Experience, Mel Gibson shared a revelation that left host Joe Rogan completely stunned. Gibson discussed how three of his close friends, who were all facing the daunting challenge of stage four cancer, managed to overcome their illnesses. This revelation was not only astonishing but also sparked curiosity and hope.

Gibson, known for his acting prowess, spoke candidly about the ‘serious stuff’ his friends were dealing with. He revealed that these friends had turned to two drugs, ivermectin and fenbendazole, which are traditionally used to combat infections like roundworms and threadworms.

To Gibson’s amazement, after using these medications, he claimed that โ€˜they donโ€™t have cancer right now.โ€™ This was a statement that not only left Rogan awestruck but also introduced a spark of hope for those listening, as Gibson earnestly declared, โ€˜This stuff works, man.โ€™

Although Gibson’s claims are hopeful, some research supports the idea that fenbendazole can effectively halt the growth of cancer cells. Yet, experts urge caution, highlighting the need to be wary of serious side effects that accompany the treatment.

During the podcast, Gibson conveyed his belief that there is a natural cure for every ailment mankind faces, even if it is not yet proven. He elaborated, โ€˜I don’t believe that there is anything that can afflict mankind that hasnโ€™t got a natural cure for it. It just makes sense to me.โ€™ He then added, โ€˜I couldnโ€™t prove that, but I just believe that. Thereโ€™s got to be something that cures things.โ€™

In awe of the discussion, Rogan commented on the matter, saying, โ€˜When you hear about things that are demonized and they turn out to be effective, you always wonder, โ€œWhat is going on here? How have our medical institutions failed us so that things that do cure you are not promoted because theyโ€™re not profitable?โ€โ€™

Despite the intriguing stories shared by Gibson, medical experts remain cautious. Dr. Susanne Arnold, associate director for clinical translation at the Markey Cancer Center in Kentucky, shared insight with The Associated Press in 2024. She cautiously noted that while pre-clinical studies show potential for drugs like ivermectin to decelerate cancer cell growth in lab settings, this doesn’t equate to successful treatment in humans. โ€˜I know of no reports of clinical trials that yielded successful results in humans with cancer,โ€™ she stated, underlining the importance of validated medical research.

This episode underscores an essential dialogue about exploring alternative approaches while emphasizing the importance of scientific scrutiny and clinical trials. Gibson’s story, while inspiring, also serves as a reminder of the ongoing quest for innovative cancer treatments. As discussions continue, there’s a collective hope for breakthroughs that blend modern medicine with new possibilities, striving for a future where such stories of survival become more common.